About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2118 blog entries.

Arizona

The Board of Pharmacy issued a Notice of Supplemental Proposed Rulemaking 4 AAC 23 related to pharmacist delegation/technician rules; see pages 339-343. A public hearing has been scheduled for March 9 at 9:00 a.m. (local time). Please note the current proposal excludes a pharmacist’s delegation of vaccine administration by a technician which was the issue of concern in the former rules package.  Please recall the technician rules package was removed from the Governor’s Regulatory Review Council’s December 2021 agenda prior to the meeting by the Board of Pharmacy over concerns expressed about technician vaccine administration.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-03-04T09:50:54-05:00March 4, 2022|Arizona|

California

The Department of Health Care Services posted the following alerts to the Medi-Cal Rx Web Portal: 

Also in California, the Board of Pharmacy published its March issue of “The Script.”  This issue includes the following articles about:  

  • New pharmacy laws in 2022. 
  • Pharmacy issues related to COVID-19 vaccination programs. 
  • Mix-ups related to COVID-19 age requirements.
  • A new vendor for submitting prescription data to CURES. 
  • A Board policy statement on compounding requirements. 
  • Mitigation strategies for preventing pharmacy drug diversion. 
  • The important role and responsibilities for pharmacists-in-charge. 
  • Listening sessions for pharmacy technicians. 
  • New public members appointed to the Board. 
  • New ad hoc committees on medication errors and workforce issues and on standard of care. 
  • Summaries of disciplinary actions ordered July 1 through December 31, 2021.

Also in California, the Office of Administrative Law has issued a Notice of Approval for amendments to the Code of Regulations’ Division 17 of Title 16, section 1715.6, related to Reporting Drug Loss, effective April 1. 

Finally in California, the following Pharmacy Law waivers issued pursuant to Business and Professions Code section 4062 expired on February 28.  

Other waivers still in effect are posted online under Pharmacy Law Waivers. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-03-04T09:50:20-05:00March 4, 2022|California|

Connecticut

The Connecticut Department of Consumer Protection adopted regulations under RCSA 20-576 to establish standards for shared pharmacy services, which are systems in which two or more licensed pharmacies process or dispense a prescription.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-03-04T09:49:09-05:00March 4, 2022|Connecticut|

Georgia

The Georgia Department of Public Health is asking for our assistance in gathering prescription data (de-identified) for the most prescribed hepatitis C antivirals. A work group at the Department is trying to determine which physicians in Georgia routinely diagnose and treat hepatitis C. As an example, the Department would be interested in data that might show hypothetically that “Dr. Brown in Albany, Georgia prescribed Harvoni to 500 patients in Georgia in 2021.” Ideally, the Department would like the data for Mavyret, Harvoni and Epclusa for 1-2 years. Please submit all data and any questions to Raybun Spelts, Clinical Pharmacist Specialist, Infectious Disease and Vaccines at the Department. His contact information is: raybun.spelts@dph.ga.gov (404)683-4949.  

Of note, the Georgia Department of Public Health has personally reached out to thank chain drug pharmacy for being willing to try to assist the Department in this health initiative.  

Also, the Georgia Pharmacy Association is looking for the team that will shape the future of pharmacy in Georgia and is now accepting applications for the 2022-2023 GPhA (Georgia Pharmacy Association) Board of Directors. Serving on the board is the opportunity to level the playing field and make a lasting contribution to the industry. There are two open positions: One board member at large and One Academy of Independent Pharmacy (AIP) member. If you have questions before you apply, contact Lia Andros, Governance Manager, at landros@gpha.org. The deadline for application is 11:59 p.m. EST on Saturday, March 5, 2022. Click here for more information and to submit a nomination.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-03-04T09:48:03-05:00March 4, 2022|Georgia|

Minnesota

Companion bills, SF 3154, and HF 3854, allowing pharmacists to initiate treatment for PeP (Post Exposure Prophylaxis) and PReP (Pre-Exposure Prophylaxis), have been introduced by Sen. Scott Dibble (DFL) and Rep. Athena Hollins (DFL). The language has been updated from last session, reflecting the work of a broad coalition of supporters formed by the joint efforts of NACDS, the Minnesota Retailers Association, the Minnesota Pharmacists Association, patient advocates and the bill sponsors. The bills have been referred to the appropriate committee for further consideration.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-03-04T09:47:13-05:00March 4, 2022|Minnesota|

Mississippi

The Mississippi Pharmacy Association has an opening on the Executive Committee, a member-at-Large Representative, for which all current MPhA Members may apply. This position is a two-year term and qualifies one to run for Vice President in the next two years if desired. A position on the executive committee is one that helps to guide the business of our organization. Since moving to a part-time Executive Director two years ago, this position also has several responsibilities that will require you to assist with various tasks of running the organization. Please reach out to any of our current Executive Committee members, www.mspharm.org/board or our staff if you have any questions. The deadline for application is March 15, 2022. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-03-04T09:46:08-05:00March 4, 2022|Mississippi|

New Jersey

The New Jersey Board of Medical Examiners has proposed to amend regulations under NJAC 13:35-7 to require practitioners to identify in advance psychological co-morbidities that affect prescribing and overall treatment decisions and assess whether continued opioid therapy is working to address a patient’s treatment needs. The rule also would address treatment planning, medical records, and management of chronic pain.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2022-03-04T09:44:43-05:00March 4, 2022|New Jersey|

North Carolina

NC Medicaid is receiving reports of pharmacists not utilizing the 72-hour Emergency Supply Override and the 01-No Other Coverage Identified code when applicable. Resistance to use these overrides is preventing Medicaid beneficiaries from being able to access necessary medications. As NC Medicaid providers, pharmacists are asked to please become familiar with these options and utilize them appropriately when administering the Medicaid benefit.  

Pharmacists are asked to utilize the 72-Hour Emergency Supply Override when clinically appropriate for Medications pending Prior Authorization. For Medicaid members, including Medicaid Managed Care, Pharmacy providers are encouraged to use the 72-hour emergency supply allowed for drugs requiring prior approval. Federal law requires that this emergency supply be available to Medicaid beneficiaries for drugs requiring prior approval (Social Security Act, Section 1927, 42 U.S.C. 1396r-8(d)(5)(B)). Use of this emergency supply ensures access to medically necessary medications. With use of the override, the system will bypass the prior approval requirement, if an emergency supply is indicated. The pharmacist should use a “3” in the Level of Service field (418-DI) to indicate the transaction is an emergency fill. *  Copayments apply to emergency fills and drug cost is reimbursed; however, a dispensing fee is not paid. There is no limit to the number of times the emergency supply can be used. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct.  

Pharmacists are asked to utilize the “01-No Other Coverage Identified” when a Medicaid claim rejects due to another payor on record. Medicaid is the payer of last resort, which means after any other insurance pays, Medicaid will pay. The other third-party payer must be billed as the primary payor when third party insurance exists, and then Medicaid can be billed as the secondary payor. When a claim is denied due to another payor on record being expired or terminated, the point-of-sale system will deny the claim, and the pharmacist will be prompted to submit the claim to another payer. In the event a beneficiary cannot produce another insurance or the beneficiary states they no longer have the other insurance, the pharmacy shall use the override code “01 – No Other Coverage Identified” in the Other Coverage Code claim segment 308-C8 for NCPDP D.0 transaction. * NC Medicaid will pay the pharmacy and seek payment from the third party, if appropriate. The pharmacy is not held liable for any payments made in these cases. *Codes may vary by managed care plan. This is the specific code for Medicaid Direct. 

Thank you for your time and attention to this valuable information regarding the NC Medicaid Pharmacy Benefit. If you have any questions or concerns with the utilization of these override codes, please contact Angela Smith, Director NC Medicaid Pharmacy Benefit, or the Managed Care Plans directly.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-03-04T09:44:04-05:00March 4, 2022|North Carolina|
Go to Top